近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Lee JK*, Pearson JD*, Maser BE, Ingham RJ. (2013). Cleavage of the JunB Transcription Factor by Caspases Generates a Carboxy-Terminal Fragment that Inhibits Activator Protein-1 Transcriptional Activity. Journal of Biological Chemistry. Jun 9. [Epub ahead of print] Adler JJ, Heller BL, Bringman LR, Ranahan WP, Cocklin RR, Goebl MG, Oh M, Lim HS, Ingham RJ, Wells CD. Amot130 Adapts Atrophin-1 Interacting Protein 4 to Inhibit Yes-associated Protein Signaling and Cell Growth. Journal of Biological Chemistry. May 24;288(21):15181-93. Lai, R and Ingham RJ. (2012). The pathobiology of the oncogenic tyrosine kinase NPM-ALK – a brief update. Therapeutic Advances in Hematology. Apr;4(2):119-31. (Review Article) Hegazy SA, Alshareef A, Gelebart P, Anand M, Armanious H, Ingham RJ, and Lai R. Disheveled proteins promote cell growth and tumorigenicity in ALK-positive anaplastic large cell lymphoma. Cellular Signalling. 25(1):295-307. Gelebart P, Hegazy SA, Wang P, Bone KM, Anand M, Sharon D, Hitt M, Pearson JD, Ingham RJ, Ma Y, Lai R (2012). Aberrant expression and biological significance of Sox2, an embryonic stem cell transcriptional factor, in ALK-positive anaplastic large cell lymphoma. Blood Cancer Journal. Aug 10;2:e82. Wu F, Zhang J, Wang P, Ye X, Jung K, Bone KM, Pearson JD, Ingham RJ, McMullen TP, Ma Y, Lai R. (2012). Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity. Cellular Signalling. 24(11):1989-98. Zhang J, Wang P, Dykstra M, Gelebart P, Williams D, Ingham R, Ekpe Adewuyi E, Lai R, McMullen T. (2012). Platelet Derived Growth Factor Receptor-α Promotes Lymphatic Metastases in Papillary Thyroid Cancer. Journal of Pathology. 228(2):241-50. Pearson JD, Mohammed Z, Bacani JTC, Lai R, Ingham RJ. (2012). The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein. BMC Cancer. 12:229. Pearson JD, Lee JKH, Bacani JTC, Lai R, Ingham RJ. (2012). NPM-ALK: the prototypic member of a family of oncogenic tyrosine kinases. Journal of Signal Transduction. 22012:123253. (Review Article) Zhang J, Wang P, Wu F, Li M, Sharon D, Ingham RJ, Hitt M, McMullen TP, Lai R. (2012) Aberrant expression of the transcriptional factor Twist1 promotes invasiveness in ALK-positive anaplastic large cell lymphoma. Cellular Signalling. 24(4):852-8 Pearson JD, Lee JK, Bacani JT, Lai R, Ingham RJ. (2011) NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma. International Journal of Clinical and Experimental Pathology.4(2):124-33. Wang P, Wu F, Zhang J, McMullen T, Young LC, Ingham RJ, Li L, Lai R. (2011). Serine phosphorylation of NPM-ALK, which is dependent on the auto-activation of the kinase activation loop, contributes to its oncogenic potential. Carcinogenesis. 32(2):146-53. Hegazy SA, Wang P, Anand M, Ingham RJ, Gelebart P, Lai R. (2010). The tyrosine 343 residue of nucleophosmin (NPM)-anaplastic lymphoma kinase (ALK) is important for its interaction with SHP1, a cytoplasmic tyrosine phosphatase with tumor suppressor functions. Journal of Biological Chemistry. 285(26):19813-20. Alford SC, Pearson JD, Carette A, Ingham RJ, Howard PL. (2009). Alpha-sarcin catalytic activity is not required for cytotoxicity. BMC Biochemistry. 10:9.